Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples